J&J ties up with Arrowhead over gene-silencing drug

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Johnson & Johnson has partnered with Arrowhead Pharmaceuticals to develop and sell the gene-silencing Hepatitis B drug, planning to acquire a minority stake in a possible deal that could be valued at $3.7B.
Back to articles

Actual Topics

Thu, 04 Oct 2018 14:56:00 GMT

HSBC boosts real estate, infrastructure and power teams

Seven new bankers have been hired by HSBC, as the banking and financial services company is expanding its real estate, infrastructure and power businesses, amid its intention to serve the clients among these industries.

Thu, 04 Oct 2018 14:21:35 GMT

US initial jobless claims drop 8K last week

The number of applications for US unemployment benefits dropped to 207K in the week ending September 29, while analysts expected them to slide to 214K from the previous 215K reading.

Subscribe to "Fundamental Analysis" feed

Subscribe
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request)
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request).
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.